CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DEVICE: contrast enhanced mammography|DRUG: Iodinated Contrast Media (ICM)
Sponsor: Margarita Louise Zuley
Collaborators: National Cancer Institute (NCI)